Capital One Financial’s AbbVie ABBV Stock Holding History

Capital One Financial’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	$592K	Sell	3,650 -2,676	-42%	-$389K	0.42%	49
2021 Q4	$857K	Sell	6,326 -232	-4%	-$27.4K	0.1%	89
2021 Q3	$707K	Sell	6,558 -816	-11%	-$93.2K	0.09%	94
2021 Q2	$831K	Sell	7,374 -61	-0.8%	-$6.87K	0.1%	87
2021 Q1	$805K	Sell	7,435 -1,557	-17%	-$167K	0.1%	85
2020 Q4	$963K	Sell	8,992 -215	-2%	-$20.7K	0.13%	78
2020 Q3	$806K	Sell	9,207 -531	-5%	-$50K	0.1%	118
2020 Q2	$956K	Buy	9,738 +95	+1%	+$8.36K	0.13%	118
2020 Q1	$735K	Buy	+9,643	New	+$821K	0.12%	144

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Capital One Financial's ABBV Position: Q1 2022 in Review

Capital One Financial reduced its AbbVie (ABBV) stake by 42% in Q1 2022, selling an estimated $389K and leaving 3,650 shares worth $592K. The position accounts for 0.42% of the portfolio, ranked #49.

Capital One Financial first reported a position in ABBV in Q1 2020 and has held it in 9 quarters since. The position peaked at $963K in Q4 2020. 3,051 funds tracked by Wall St. Rank hold ABBV as of Q1 2022.

Capital One Financial held 3,650 shares of AbbVie worth $592K as of Q1 2022.
Capital One Financial sold 2,676 AbbVie shares in Q1 2022, an estimated $389K.
AbbVie made up 0.42% of Capital One Financial's portfolio in Q1 2022, its #49 holding.
Capital One Financial first reported a position in AbbVie in Q1 2020 and has held it in 9 quarters since.
Capital One Financial's AbbVie position peaked at $963K in Q4 2020.
3,051 funds tracked by Wall St. Rank held AbbVie as of Q1 2022.

Based on Capital One Financial's 13F filing for Q1 2022, filed 13 Apr 2022.